Published by ChinaMNC · Tunxi
Anhui's Suixi County Chronic Disease Reform: What Foreign Founders Should Know About China's Primary Care and Insurance Payment Shift
A practical ChinaMNC brief for foreign founders on how Suixi County's shift from treatment-centered care to health management, its medical community insurance model, and its digital chronic disease platform affect the compliance and operating environment for foreign-invested healthcare and related companies in China.
Key takeaways for foreign founders
This is not a story about registering a company. It is a story about how a county in Anhui Province changed the way it pays for healthcare. For foreign founders, the relevance is indirect but real: it shows how local governments are experimenting with insurance payment models and digital health systems, which can shape opportunities and compliance expectations for foreign-invested enterprises (FIEs) in healthcare, medical devices, digital health, and insurance-adjacent services. Keep the facts below in mind when you plan a China entity, because local pilots can influence licensing, data handling, and partnership requirements.
What Suixi County actually did
According to the Anhui provincial government website, Suixi County in Huaibei City, Anhui Province, has been shifting its medical institutions from a treatment-centered model to a health-management-centered model. The county's health commission director, Wu Liang, said the aim is to act as a health gatekeeper for residents by changing incentives and improving chronic disease management at grassroots facilities.
The source reports concrete results during the 14th Five-Year Plan period: average annual inpatient spending within the county for insured residents fell from 8,509 yuan to 6,586 yuan, and the premature mortality rate for four major chronic diseases fell from 13.74% to 11.07%.
The family doctor “1+1+1” service
Suixi operates a family doctor contract service in which a county hospital doctor, a township health center doctor, and a village clinic doctor form a team to provide health management for village residents. Chen Shumin, a village clinic doctor in Daokou Village, Baishan Town, conducts home visits and says chronic disease patients are followed up at least once per quarter. She also uses family doctor WeChat groups that include doctors from the township health center and Suixi County People's Hospital, allowing villagers to consult at any time.
How the insurance payment model works
The source describes a “large lump-sum contract” arrangement. Suixi consolidated county medical units into two medical communities led by county-level public hospitals. Within each medical community, after deducting incremental fund risk reserves and critical illness insurance funds, no less than 95% of the portion based on the number of insured people in covered townships is handed to the medical community for lump-sum use. If the annual medical insurance fund has a surplus, it is distributed to medical institutions at a county, township, and village ratio of 6:3:1, mainly for salaries and performance rewards.
Chen Zhuo, head of the Suixi medical reform office, explained the logic: the less sick the insured population is, the less money is spent, and the more hospitals and doctors benefit. This forces institutions to manage health well, and lead hospitals are more willing to help township and village facilities improve.
Suixi also assigns insurance funds for 47 groups of common chronic diseases to township health centers on a per-capita lump-sum basis, with surpluses retained at a county, township, and village ratio of 4:4:2. Chen Zhuo said that because chronic disease treatment cycles are long and mainly involve outpatient and daily management, township and village institutions play a large role. In the past, assessments could only count single visits or single hospitalizations and could not measure routine management quality; per-capita management encourages more substantive contracting, follow-up, and medication guidance.
The source also states that Suixi's medical insurance fund has run a surplus for nine consecutive years and its chronic disease insurance fund for five consecutive years. Surpluses mean improved pay for medical staff.
Digital chronic disease management
Suixi integrated health records for the county's chronic disease population and built a tiered online management system. It currently covers 131,000 chronic disease patients in the county. The chronic disease pilot population increased by 4,152 year-on-year in 2025, reaching nearly 150,000. Total medical costs for the pilot population were 255.414 million yuan, down 0.18% year-on-year, and total inpatient costs were 192.5575 million yuan, down 4.07% year-on-year.
What this means for your China company registration
For most foreign founders, this article does not change the basic steps of setting up a company in China. But it is useful context if your business touches healthcare, digital health, medical devices, or insurance services. Consider these practical points:
- Local pilots can create partnership opportunities. County-level medical communities and public hospitals are the buyers and operators in this model. A foreign-invested company providing digital health tools, chronic disease management software, or medical devices may find local partners, but public hospital procurement and data rules apply.
- Data compliance matters. The source mentions integrated health records and an online management system. If your product handles patient health data in China, plan for China's personal information protection and health data rules before you register or launch.
- Entity choice still depends on your activity. A wholly foreign-owned enterprise is common for consulting, software, and trading. If your business involves medical services or certain regulated devices, negative-list restrictions and sector-specific licenses may apply. Confirm the scope with local authorities before committing capital.
- Registration basics remain the same. You will still need a company name, registered address, business scope, legal representative, capital contribution plan, and relevant documents. The source does not describe foreign investment registration, so do not treat it as a guide to entity setup.
- Insurance payment experiments can signal market direction. Payment reforms that reward prevention and per-capita management may increase demand for chronic disease management tools and grassroots healthcare services. That can inform your business plan, but it is not a guarantee of market access or revenue.
Practical checklist before you register
- Define whether your China entity will sell software, devices, consulting, or clinical services, because the business scope and licenses differ.
- Check whether your sector appears on the foreign investment negative list and whether local rules require a Chinese partner.
- Prepare a data compliance plan if you will process health or personal information.
- Identify local partners such as hospitals, medical communities, or distributors, and confirm procurement rules.
- Keep capital and tax planning separate from pilot program claims; the source provides no tax or registration incentives for foreign founders.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.
Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.